Heart disease showdown: surgery vs. pills over 10 years

NCT ID NCT04894877

Ongoing Knowledge-focused Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows over 5,000 people with stable heart disease who were previously treated with either an invasive strategy (like stents or bypass surgery) plus medication, or medication alone. Researchers want to see which approach leads to better survival over 10 years. The goal is to give patients and doctors clearer information on the best long-term management for coronary artery disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide clear evidence on whether an initial invasive strategy (stents or bypass surgery) or medical therapy alone is better for long-term survival in stable heart disease patients.
What could go wrong: This is an observational follow-up of a completed trial, not a new treatment test. Results may show no clear difference between strategies, and findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder coronary artery disorder Coronary Disease heart disorder myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES CORONARY ARTERY DISEASE CORONARY DISEASE HEART DISEASES MYOCARDIAL ISCHEMIA

More trials for these conditions

Other studies related to the condition(s) this trial covers.